1Cascinu S, Graziano F, Barni S, et al. A phase Ⅱ study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. Br J Cancer, 2001,84:470-474.
2Heath El, Urba S, Marshall J, et al. Phase Ⅱ trial of docetaxel chemotherapy in patients with incurable adenocareinoma of the esophagus. Invest New Drugs, 2002,20 : 95-99.
3Wohrer1 SS,Raderer M,Hejna M.Palliative chemothera-py for advanced gastric cancer[J].Ann Oncol,2004,15(11):1585-1595.
4Shen YC,Chou CJ,Chiou WF,et al.Anti-inflammatory ef-fects of the partially purified extract of radix Stephaniaetetrandrae:comparative studies of its active principles te-trandrine and fangchinoline on human polymorphonuclearleukocyte functions[J].Mol Pharmacol,2001,60(5):1083-1090.
5Nomura M,Yamazaki R,Takaya M,et al.Inhibition of te-trandrine on epidermal growth factor-induced cell trans-formation and its signal transduction[J].Anticancer Res,2007,27(5A):3187-3193.
6Jang BC,Lim KJ,Paik JH,et al.Tetrandrine-inducedapoptosis is mediated by activation of caspases and PKC-delta in U937 cells[J].Biochem Pharmacol,2004,67(10):1819-1829.
7Wei J,Liu BR,Wang L,et al.Synergistic interaction be-tween tetrandrine and chemotherapeutic agents and influ-ence of tetrandrine on chemotherapeutic agent-associatedgenes in human gastric cancer cell lines[J].CancerChemother Pharmacol,2007,60(5):703-711.
8Chou TC,Talalay P.Quantitative analysis of dose-effectrelationships:the combined effects of multiple drugs orenzyme inhibitors[J].Adv Enzyme Regul,1984,22:27-55.
10Papadaki C,Mavroudis D,Trypaki M,et al.Tumoral ex-pression of TXR1 and TSP1 predicts overall survival ofpatients with lung adenocarcinoma treated with first-linedocetaxel-gemcitabine regimen[J].Clin Cancer Res,2009,15(11):3827-3833.
